Fermenta Biotech Limited (BOM:506414)
India · Delayed Price · Currency is INR 320.60
-8.10 (-2.46%)
At close: Jun 16, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 9.44 billion as of June 16, 2026. Its market cap has increased by 9.03% in one year.
Market Cap
9.44B
Enterprise Value
10.10B
Revenue
5.25B
Ranking
n/a
PE Ratio
13.08
Stock Price
320.60
Market Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 9.44B, an increase of 2,709.89%. That is a compound annual growth rate of 12.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 9.44B | -7.87% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 13.65B |
| Syncom Formulations (India) | 13.61B |
| Fredun Pharmaceuticals | 12.76B |
| Lincoln Pharmaceuticals | 12.72B |
| TTK Healthcare | 12.57B |
| Wanbury | 9.32B |
| Bharat Parenterals | 9.12B |
| Sudarshan Pharma Industries | 8.95B |